COVID-19: Uniklinikum Dresden, for the first time successfully Remdesivir – Naturopathy naturopathy specialist portal

COVID-19: Uniklinikum Dresden, for the first time successfully Remdesivir – Naturopathy naturopathy specialist portal

COVID-19-treatment with Remdesivir at the University hospital of Dresden

In the treatment of severe COVID-19-cases, a lot of hopes resting on the drug Remdesivir, whose efficacy has been demonstrated in the first studies already. Although the activity against the Coronavirus SARS-CoV-2 is not considered occupied, so far as sufficient, but the drug in practice is already used for severe disease. So, now at the University hospital of Dresden, where a seriously ill patient treated successfully with Remdesivir was.

The originally for the treatment of Ebola developed drug is Remdesivir as a possible therapeutic agent in severe COVID-19-cases. At the University hospital Carl Gustav Carus, Dresden, has now been treated the first patient to be successfully with the anti-viral active ingredient. The previously seriously ill 53-year-old patient recovered quickly and was able to leave the hospital again, the message of the University hospital.

Two-week intensive medical treatment

A total of two weeks, the 53-year-old nurse, Jenny fishermen had to be treated on the intensive care unit of the clinic for anaesthesiology and intensive care therapy, Dresden, seven days of which it was ventilated mechanically. “Because of the condition of the patient was deteriorated after the transfer from görlitz hospital dramatically, the intensive care specialist at the University hospital for the gift of the present only in the context of studies applicable Remdesivir”, according to the University hospital of Dresden.

Requirements for the Remdesivir application

The application of Remdesivir against COVID-19 in Germany within the Federal Institute for drugs and medical devices (BfArM) confirmed the compassionate use program possible and is currently being tested in clinical trials, in which the University hospital Carl Gustav Carus Dresden involved. The first seriously ill patient could benefit in Dresden of this possibility.

“I have given myself in the hands of the people here at the hospital, because I knew I could only survive so,” says the 53-Year-old. The Corona-Virus someone like you, who had no previous health problems, so ill, you have not believed. “Before the relocation to Dresden, I had my breathing problems, scared to death,” says Jenny Fischer.

Treatment of severe COVID-19-cases, a challenge

According to Professor Michael Albrecht, Medical Board of the University hospital of Dresden, the intensive medical care of patients with particularly severe COVID-19-gradients for the intensive care of a University hospital is a major challenge. “But over many years built up Expertise and the networking with colleagues from all over the world enable us therapies on the current state of medicine. That we can save this way of life, shows the importance of the University’s cutting-edge medicine,“ says Prof. Albrecht.

“The gift of Remdesivir is one of several options, COVID-19-patients with specific, but not to provide in the Routine clinical practice of established therapies,” adds the Director of the clinic for anaesthesiology and intensive care therapy, University hospital Dresden, Professor Thea Koch.

Breaking new ground in the treatment

With the initial administration of the antiviral drug, you would have to enter, in good conscience, Neuland, because the care for the most severely ill people daily life on their intensive care unit, and regularly going to new treatment ways, in close networking with colleagues from around the world, says Prof. chef. In addition, it had managed to get “after the decision for the gift of Remdesivir in the case of this patient, the medication in the very short term.”

Healing in two weeks

The COVID-19-patient Jenny Fischer of the health condition improved under treatment with Remdesivir, mechanical ventilation, prone position therapy, as well as a supply of the present peripheral pulmonary artery embolisms relatively quickly. Already after a week of invasive mechanical ventilation could be stopped. In the meantime, the patient was discharged from the hospital. 16 days later, the 53-Year-old now regularly breathing exercises, which are to be continued in the coming weeks in a rehabilitation clinic is intensive.

“I can’t understand the people who protect themselves from the Corona Virus or the disease play down” is Jenny Fischer, quoted in the press release of the University hospital. And Professor Michael Albrecht stresses that COVID-19 should not be underestimated because of the sometimes very long and medically complex gradients to. Here are the need for specialized’m going to intensive care units is particularly pronounced. (fp)